Total Payments
$36,192
2023 Payments
$17.21
Companies
34
Transactions
491
Medicare Patients
15,006
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$17,650 (48.8%)
Food & Beverage$7,463 (20.6%)
Consulting$6,382 (17.6%)
Travel$4,170 (11.5%)
Education$526.51 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,650 | 11 | 48.8% |
| Food and Beverage | $7,463 | 440 | 20.6% |
| Consulting Fee | $6,382 | 6 | 17.6% |
| Travel and Lodging | $4,170 | 23 | 11.5% |
| Education | $526.51 | 11 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16,508 | 70 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,391 | 48 | $0 (2022) |
| Lilly USA, LLC | $2,813 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,788 | 81 | $0 (2022) |
| Medtronic Vascular, Inc. | $1,395 | 17 | $0 (2020) |
| Boston Scientific Corporation | $1,341 | 12 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $487.22 | 30 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $456.87 | 30 | $0 (2022) |
| Novo Nordisk Inc | $402.18 | 34 | $0 (2020) |
| Merck Sharp & Dohme LLC | $352.57 | 40 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.21 | 1 | Boston Scientific Corporation ($17.21) |
| 2022 | $1,229 | 33 | Lilly USA, LLC ($450.00) |
| 2021 | $419.73 | 24 | AstraZeneca Pharmaceuticals LP ($171.39) |
| 2020 | $1,978 | 58 | AstraZeneca Pharmaceuticals LP ($1,400) |
| 2019 | $6,713 | 99 | Novartis Pharmaceuticals Corporation ($5,271) |
| 2018 | $12,602 | 125 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,963) |
| 2017 | $13,233 | 151 | Novartis Pharmaceuticals Corporation ($11,060) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2023 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: ACCOLADE_CRM | ||||||
| 12/16/2022 | Boston Scientific Corporation | General - Tachy (Device) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: General - Tachy_CRM | ||||||
| 11/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Cardio-renal | ||||||
| 11/01/2022 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Food and Beverage | In-kind items and services | $81.14 | General |
| Category: Drug-Coated Balloons | ||||||
| 11/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/30/2022 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $74.95 | General |
| Category: Stents | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardio-renal | ||||||
| 10/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Cardio-renal | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.88 | General |
| 07/19/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/07/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/29/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardio-renal | ||||||
| 06/29/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Cardio-renal | ||||||
| 06/23/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: Cardiovascular | ||||||
| 06/14/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardio-renal | ||||||
| 04/28/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2022 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $36.81 | General |
| Category: Airway Clearance Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,445 | 1,670 | $167,568 | $57,592 |
| 2022 | 33 | 4,145 | 6,183 | $1.6M | $355,297 |
| 2021 | 42 | 4,594 | 7,091 | $1.8M | $415,364 |
| 2020 | 45 | 4,822 | 7,065 | $1.9M | $411,215 |
Total Patients
15,006
Total Services
22,009
Medicare Billing
$1.2M
Procedure Codes
142
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 323 | 328 | $49,252 | $15,669 | 31.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 17 | 22 | $19,140 | $8,676 | 45.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 64 | $24,960 | $8,623 | 34.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 96 | $13,440 | $5,962 | 44.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 77 | 77 | $12,166 | $4,236 | 34.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 22 | $13,420 | $3,871 | 28.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 425 | 574 | $11,480 | $3,393 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 14 | $4,060 | $1,568 | 38.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 86 | 87 | $4,350 | $1,544 | 35.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 82 | 82 | $3,280 | $1,242 | 37.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 47 | 51 | $2,652 | $910.39 | 34.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 82 | 82 | $2,460 | $824.21 | 33.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 47 | 53 | $5,088 | $489.80 | 9.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 47 | 51 | $714.00 | $267.81 | 37.5% |
| 93923 | Complete ultrasound study of arm and leg arteries | Facility | 2023 | 16 | 16 | $800.00 | $256.95 | 32.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 47 | 51 | $306.00 | $58.79 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,017 | 1,898 | $256,230 | $104,805 | 40.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 248 | 295 | $226,954 | $33,341 | 14.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 99 | 101 | $239,481 | $33,264 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 333 | $65,268 | $29,947 | 45.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 116 | 327 | $45,780 | $17,828 | 38.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 35 | 40 | $110,360 | $17,580 | 15.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 134 | 156 | $40,092 | $15,721 | 39.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 81 | 324 | $44,641 | $13,739 | 30.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 66 | 68 | $123,964 | $11,765 | 9.5% |
About Dr. Damoder Kesireddy, M.D
Dr. Damoder Kesireddy, M.D is a Interventional Cardiology healthcare provider based in Bryan, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134173925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damoder Kesireddy, M.D has received a total of $36,192 in payments from pharmaceutical and medical device companies, with $17.21 received in 2023. These payments were reported across 491 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,650).
As a Medicare-enrolled provider, Kesireddy has provided services to 15,006 Medicare beneficiaries, totaling 22,009 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Bryan, OH
- Active Since 05/19/2006
- Last Updated 07/01/2024
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1134173925
Products in Payments
- ENTRESTO (Drug) $12,374
- JARDIANCE (Drug) $9,917
- FARXIGA (Drug) $1,382
- JETSTREAM (Device) $1,258
- TurboHawk (Device) $675.26
- BRILINTA (Drug) $637.91
- HawkOne (Device) $618.63
- XARELTO (Drug) $456.87
- Kerendia (Drug) $299.73
- PRALUENT (Drug) $247.47
- Saxenda (Drug) $148.87
- JANUVIA (Drug) $144.42
- ELIQUIS (Drug) $141.14
- Vascepa (Drug) $135.97
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $134.70
- SYMBICORT (Drug) $126.32
- BYDUREON (Drug) $125.00
- BEVESPI AEROSPHERE (Drug) $116.55
- STIOLTO RESPIMAT (Drug) $114.76
- ANORO (Drug) $106.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.